Carrie Krehlik serves as Executive at Global Blood Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Carrie Krehlik has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 5, 2022 involved selling 6,716 shares valued at $0.
Carrie Krehlik currently holds 6,716 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carrie Krehlik has been a net neutral trader of GBT stock. They have purchased $0 and sold $0 worth of shares.
Carrie Krehlik's most recent insider trade was on Oct 5, 2022, when they sold 6,716 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $68.15 |
| Discretionary |
| Sep 1, 2022 | GBT | $0 | Option Exercise | 8,060 | $N/A | Discretionary |
| Sep 1, 2022 | GBT | $0 | Option Exercise | 2,208 | $N/A | Discretionary |